Anti-ALK (Anaplastic Lymphoma Kinase) / CD246, clone ALK/1503

Anti-ALK (Anaplastic Lymphoma Kinase) / CD246, clone ALK/1503
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NEO-238-MSM3-P0 20 µg - -

Request delivery time estimate

326.00€
NEO-238-MSM3-P1 100 µg - -

Request delivery time estimate

704.00€
 
Formulation: Purified Ab with BSA and Azide at 200ug/ml. Cellular Localization: Cell membrane.... more
Product information "Anti-ALK (Anaplastic Lymphoma Kinase) / CD246, clone ALK/1503"
Formulation: Purified Ab with BSA and Azide at 200ug/ml. Cellular Localization: Cell membrane. Positive Control: Anaplastic Large Cell Lymphoma. Chromosome Location: 2p23. Protein Function: Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed:11121404, PubMed:11387242, PubMed:16317043, PubMed:17274988, PubMed:30061385, PubMed:34646012, PubMed:34819673). Also acts as a key thinness protein involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a negative regulator of white adipose tissue lipolysis and sympathetic tone to fine-tune energy homeostasis (By similarity). Following activation by ALKAL2 ligand at the cell surface, transduces an extracellular signal into an intracellular response (PubMed:30061385, PubMed:33411331, PubMed:34646012, PubMed:34819673). In contrast, ALKAL1 is not a potent physiological ligand for ALK (PubMed:34646012). Ligand-binding to the extracellular domain induces tyrosine kinase activation, leading to activation of the mitogen-activated protein kinase (MAPK) pathway (PubMed:34819673). Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif (PubMed:15226403, PubMed:16878150). Induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1 (PubMed:15226403, PubMed:16878150). ALK activation may also be regulated by pleiotrophin (PTN) and midkine (MDK) (PubMed:11278720, PubMed:11809760, PubMed:12107166, PubMed:12122009). PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation (PubMed:11278720, PubMed:11809760, PubMed:12107166). MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction (PubMed:12122009). Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase (PubMed:15226403, PubMed:16878150). Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK (PubMed:15226403, PubMed:16878150) [The Uniprot Consortium]
Keywords: Anti-ALK, Anti-Anaplastic lymphoma kinase, Anti-ALK tyrosine kinase receptor, 559
Supplier: NeoBiotechnologies
Supplier-Nr: 238-MSM3

Properties

Application: FC, IF, WB
Antibody Type: Monoclonal
Clone: ALK/1503
Conjugate: No
Host: Mouse
Species reactivity: human
MW: 80/200 kD
Format: Purified

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-ALK (Anaplastic Lymphoma Kinase) / CD246, clone ALK/1503"
Write a review
or to review a product.
Viewed